GonzalezBello´s Group's Avatar

GonzalezBello´s Group

@cgbello

19
Followers
15
Following
13
Posts
18.12.2024
Joined
Posts Following

Latest posts by GonzalezBello´s Group @cgbello

Best AMR papers of 2025 An unprecedent collaboration between two journals AAC and JID to present the best AMR papers of 2025.

Proud to announce that our collaborative paper with INIBIC on antimicrobial resistance caused by bacteria producing OXA-48 @cgbello.bsky.social @usc.gal @ciqus.bsky.social
has been selected as one of the best AMR paper of 2025
👇
asm.org/podcasts/edi...

23.02.2026 13:42 👍 2 🔁 0 💬 0 📌 0
Post image

Campeonato de España de Orientación 2026, modalidad sprint, Málaga
Medalla de Oro....🙂... @cgbello.bsky.social

Gracias a la FEGADO y al club Compás por el apoyo
seguimos 💪💪💪💪

23.02.2026 13:32 👍 0 🔁 0 💬 0 📌 0
Post image

A new collaborative study between INIBIC, @cgbello.bsky.social @usc.gal @ciqus.bsky.social and ANTABIO. The work uncovers the key role of fluorine in boosting Palibactam, a novel DBO inhibitor, activity against CRAB infections. Published in AAC 😊
journals.asm.org/doi/10.1128/...

19.02.2026 16:40 👍 3 🔁 1 💬 1 📌 0
Preview
Biocompatible TADF Probes for Highly Multiplexed Fluorescence Lifetime Imaging A collection of thermally activated delayed fluorescence (TADF) emitters were formulated into biocompatible nanoprobes for live-cell fluorescence lifetime imaging. A total of 36 TADF nanoprobes enabl...

Glad to be involved in this amazing work on the simultaneous imaging of five nanoprobes within a single spectral window published in Angew. Chemie
onlinelibrary.wiley.com/doi/10.1002/...
@cgbello.bsky.social @usc.gal @ciqus.bsky.social

19.01.2026 09:56 👍 2 🔁 0 💬 0 📌 0

Grateful to the Galician Innovación Agency for awarding the proposal of the GI-2155 group "Enzyme Inhibitors and Chemical Tolls in Biology" of @usc.gal at @ciqus.bsky.social as a competitive reference group
Four more years of funding to achieve exciting and Innovación research
Be tuned 💪

01.08.2025 09:58 👍 4 🔁 1 💬 0 📌 0
Post image

If you are interested in the in vivo development of resistance of pseudomonas aeruginosa to cefiderocol, the latest aproved antibiotic, don't miss this collaborative work with
CHUAC @cgbello.bsky.social @usc.gal @ciqus.bsky.social

journals.asm.org/doi/10.1128/...

03.07.2025 06:24 👍 3 🔁 1 💬 0 📌 0
Post image Post image

Campeonato de España de Orientación 2025. El Pedroso, Sevilla.
Campeona de España distancia media 🥇y subcampeona distancia larga🥈 @cgbello.bsky.social @culturausc.bsky.social
Gracias a #fegado y el #ClubOrientaciónCompás por el apoyo y a la #fedo por la organización
Seguimos....😍

21.04.2025 12:46 👍 1 🔁 0 💬 0 📌 0
Post image Post image

GALA FEDO 2024. Entrega de medallas liga nacional de orientación modalidad sprint. 3° puesto.
cgbello.bsky.social
Seguimos💪💪💪💪💪💪

08.02.2025 18:35 👍 1 🔁 0 💬 0 📌 0
Preview
O CiQUS abre as portas ás preuniversitarias para compartir unha xornada con científicas referentes | Universidade de Santiago de Compostela Coa declaración do 11 de febreiro como Día das Mulleres e as Nenas na Ciencia, a ONU busca lograr o acceso e a participación plena e equitativa na ciencia para as mulleres e as nenas. Co gallo desta c...

www.usc.gal/gl/xornal/no...

CiQUS opens its doors to share a day with leading scientists
@cgbello.bsky.social @ciqus.bsky.social @usc.gal

Precision Antibiotics - from Design to Practice, a project by Concepción González-Bello (IP), Mª Carmen Outeiral Valiño and María Maneiro Rey.

05.02.2025 12:01 👍 3 🔁 0 💬 0 📌 0
Preview
Que enfermidade infecciosa será a maior ameaza para a saúde humana en 2025? A malaria, o VIH e a tuberculose causan dous millóns de mortes ao ano en todo o mundo, pero é a gripe aviaria a que está no punto de mira

🦠 A malaria, o VIH e a tuberculose matan dous millóns de persoas ao ano. Porén, hai un patóxeno que está a xerar unha gran preocupación e que pode xerar un grave problema de saúde pública en 2025.

Cóntannolo en @es.theconversation.com 👇

02.01.2025 09:35 👍 0 🔁 1 💬 0 📌 0
Preview
High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine Abstract. A bisbenzamidine DNA binding agent can be easily dimerized by alkylation of its terminal amidine groups to afford an extended minor groove binder

Interested in antileishmanial drug Discovery and DNA binding?
Take a look of our collaborative work in the field just published in NAR Molecular Medicine
👇
High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine
academic.oup.com/narmolmed/ar...

30.12.2024 17:58 👍 0 🔁 0 💬 0 📌 0
Ayudas para contratos Juan de la Cierva 2024 | Agencia Estatal de InvestigaciónBuscar Las ayudas Juan de la Cierva tienen como finalidad fomentar la incorporación de jóvenes, en posesión del grado de doctor, con objeto de que completen su formación investigadora postdoctoral en centros de I+D españoles.

Recruiting postdocs (PhD after Jan 2023) with a competitive CV to apply the Juan de la Cierva grant in Precision Antibacterial Agents

cgbello.bsky.social at usc.gal.bsky.social ciqus.bsky.social

www.gonzalezbello.com
👇
Deadline: January 17 2025

www.aei.gob.es/convocatoria...

18.12.2024 13:41 👍 0 🔁 0 💬 0 📌 0

Moitas grazas a gciencia.bsky.social por facerse eco da nosa investigación cgbello.bsky.social‬ na usc.gal.bsky.social
sobre a loita fronte as bacterias hospitalarias máis desafiantes.

18.12.2024 12:02 👍 2 🔁 1 💬 0 📌 0
Preview
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes | Antimicrobial Agents and Chemotherapy Among the different species of Enterobacterales equipped with chromosomal AmpC, Enterobacter cloacae complex, Klebsiella aerogenes, and Citrobacter freundii are considered those with the highest risk ...

Interested in in vivo resistance to ceftazidime/avibactam in Klebsiella aerogenes?
Take a look of our collaborative work published in Antimicrob. Agents Chemother. 2024, 68, e01307-2
cgbello.bsky.social
usc.gal.bsky.social
👇
journals.asm.org/doi/abs/10.1...

18.12.2024 11:55 👍 0 🔁 0 💬 0 📌 0